One Psilocybin Trip Can Deliver Two Years Of Depression Relief.

A 2025 study reported in ScienceDaily highlights that a single dose of psilocybin produced significant and sustained reductions in depression for cancer patients—lasting up to 2 years after treatment.

It tracked symptom scores before treatment, then at intervals over two years. Nearly all participants maintained or further improved their mood after the initial antidepressant effect, suggesting long-lasting therapeutic benefits from just one session.

For cancer patients facing chronic depression, psilocybin offers a promising, potentially transformative option. If you’re exploring alternatives, this could be a powerful option under medical supervision.